AZD-8330 - CAS 869357-68-6
Catalog number: 869357-68-6
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
MEK
Description:
AZD8330 is an orally active, selective MEK inhibitor with potential antineoplastic activity. AZD8330 specifically inhibits mitogen-activated protein kinase kinase 1 (MEK or MAP/ERK kinase1), resulting in inhibition of growth factor-mediated cell signaling and tumor cell proliferation.
Publictions citing BOC Sciences Products
  • >> More
Purity:
0.98
Appearance:
White to off-white Solid
Synonyms:
AZD8330; AZD 8330; ARRY-424704; ARRY-704.
MSDS:
Inquire
Current Developer:
AstraZeneca.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related MEK Products


CAS 869357-68-6 AZD-8330

AZD-8330
(CAS: 869357-68-6)

AZD8330 is an orally active, selective MEK inhibitor with potential antineoplastic activity. AZD8330 specifically inhibits mitogen-activated protein kinase kina...

CAS 871700-17-3 Trametinib

Trametinib
(CAS: 871700-17-3)

Trametinib is a highly specific and potent MEK1/2 inhibitor with IC50 of 0.92 nM/1.8 nM and no inhibition of the kinase activities of c-Raf, B-Raf, ERK1/2.

CAS 1035555-63-5 TAK-733

TAK-733
(CAS: 1035555-63-5)

TAK-733 is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity. MEK inhibitor TAK-733 selectively b...

CAS 1236699-92-5 Pimasertib

Pimasertib
(CAS: 1236699-92-5)

Pimasertib, also known as AS703026, SAR245509, MSC1936369B, is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineop...

CAS 934660-93-2 Cobimetinib

Cobimetinib
(CAS: 934660-93-2)

cobimetinib, also known as GDC-0973 and XL-518, is an orally bioavailable small-molecule inhibitor of mitogen-activated protein kinase kinase 1 (MAP2K1 or MEK1)...

CAS 305350-87-2 SL327

SL327
(CAS: 305350-87-2)

SL327 is a MEK inhibitor. SL327 blocks acquisition but not expression of lithium-induced conditioned place aversion. SL327 had no affect on acquisition, expres...

CAS 923032-37-5 Refametinib

Refametinib
(CAS: 923032-37-5)

Refametinib, also known as RDEA119, BAY 86-9766, is an orally bioavailable selective MEK inhibitor with potential antineoplastic activity. MEK inhibitor RDEA119...

CAS 934662-91-6 Cobimetinib racemate

Cobimetinib racemate
(CAS: 934662-91-6)

Cobimetinib racemate is a selective inhibitor of MEK. It is also known as mitogen activated protein kinase kinase (MAPKK) and is a key component of the RAS/RAF/...

CAS 946128-88-7 RO5126766

RO5126766
(CAS: 946128-88-7)

RO5126766, also known as CH5126766, is a protein kinase inhibitor specific for the Raf and MEK mitogen-activated protein kinases (MAPKs) with potential anti-ne...

Cobimetinib hemifumarate
(CAS: 1369665-02-0)

Cobimetinib, also known as GDC-0973 and XL-518, is a novel selective MEK inhibitor, and the IC50value against MEK1 is 4.2 nM, with potential antineoplastic acti...

CAS 934660-94-3 Cobimetinib (R-enantiomer)

Cobimetinib (R-enantiomer)
(CAS: 934660-94-3)

Cobimetinib (R-enantiomer) is a selective inhibitor of MEK. It is also known as mitogen activated protein kinase kinase (MAPKK) and is a key component of the RA...

CAS 2002381-25-9 APS-2-79

APS-2-79
(CAS: 2002381-25-9)

APS-2-79 is a small molecule antagonist of MEK phosphorylation by RAF through direct binding of the KSR active site, and antagonizes oncogenic Ras signalling (I...

CAS 874101-00-5 RO4987655

RO4987655
(CAS: 874101-00-5)

RO4987655 is an orally active small molecule, targeting mitogen-activated protein kinase kinase 1 (MAP2K1 or MEK1), with potential antineoplastic activity. MEK ...

CAS 334949-59-6 BIX02188

BIX02188
(CAS: 334949-59-6)

CAS 167869-21-8 PD98059

PD98059
(CAS: 167869-21-8)

PD98059 is a potent and selective inhibitor of MAP kinase kinase (also known as MAPK/ERK kinase or MEK kinase). It mediates its inhibitory properties by binding...

CAS 212631-79-3 CI-1040

CI-1040
(CAS: 212631-79-3)

CI-1040 is a MEK inhibitor, which demonstrated in vivo activity in preclinical animal models and subsequently became the first MEK inhibitor to enter clinical t...

CAS 1168091-68-6 GDC-0623

GDC-0623
(CAS: 1168091-68-6)

GDC-0623 is an orally active, selective MEK inhibitor with potential antineoplastic activity. MEK inhibitor GDC-0623 specifically inhibits mitogen-activated pro...

CAS 606143-89-9 Binimetinib

Binimetinib
(CAS: 606143-89-9)

Binimetinib is an oral, highly selective MEK inhibitor.

CAS 391210-10-9 PD-0325901

PD-0325901
(CAS: 391210-10-9)

PD-0325901 i a potent bioavailable and selective MEK inhibitor, which targets mitogen-activated protein kinase kinase (MAPK/ERK kinase or MEK) with potential an...

CAS 334951-92-7 BIX 02188

BIX 02188
(CAS: 334951-92-7)

Selective dual MEK5 kinase inhibitor, with IC50 values of 4.3, 810, 1800, and >6300 nM for MEK5, ERK5, TGFbR1 and other closely related kinases respectively.

Chemical Structure

CAS 869357-68-6 AZD-8330

Quick Inquiry

Verification code

Featured Items